col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


433 Results       Page 1

 [1] 
MDPI AG: International Journal of Molecular Sciences
  original article Date Title Authors   All Authors
1 [GO] 2022―May―18 Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels Anne Caufriez, Andrés Tabernilla, Raf Van Campenhout, Axelle Cooreman, Kaat Leroy, Julen Sanz Serrano, et al. (+5)
2 [GO] 2022―May―17 Structure-Based Development of SARS-CoV-2 Spike Interactors Flavia Squeglia, Maria Romano, Luciana Esposito, Giovanni Barra, Pietro Campiglia, Marina Sala, et al. (+3)
3 [GO] 2022―May―16 A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab Margherita Passariello, Veronica Ferrucci, Emanuele Sasso, Lorenzo Manna, Rosa Rapuano Lembo, Stefano Pascarella, et al. (+4)
4 [GO] 2022―May―11 Antiviral Characterization of Advanced Materials: Use of Bacteriophage Phi 6 as Surrogate of Enveloped Viruses Such as SARS-CoV-2 Ángel Serrano-Aroca
5 [GO] 2022―May―10 The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review Monika Gudowska-Sawczuk, Barbara Mroczko
6 [GO] 2022―May―10 Dimerization Tendency of 3CLpros of Human Coronaviruses Based on the X-ray Crystal Structure of the Catalytic Domain of SARS-CoV-2 3CLpro Seri Jo, Hwa Young Kim, Dong Hae Shin, Mi-Sun Kim
7 [GO] 2022―May―08 Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70 Lydia C. Kitchen, Marvin Berman, James Halper, Paul Chazot
8 [GO] 2022―May―06 Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19 Atsushi Tanaka, Koichi Node
9 [GO] 2022―May―05 Shared Inflammatory Pathology of Stroke and COVID-19 Kathryn E. Sánchez, Gary A. Rosenberg
10 [GO] 2022―May―04 SARS-CoV-2 Infection Dysregulates Cilia and Basal Cell Homeostasis in the Respiratory Epithelium of Hamsters Tom Schreiner, Lisa Allnoch, Georg Beythien, Katarzyna Marek, Kathrin Becker, Dirk Schaudien, et al. (+9)
11 [GO] 2022―May―04 Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells Ilaria Caputo, Brasilina Caroccia, Ilaria Frasson, Elena Poggio, Stefania Zamberlan, Margherita Morpurgo, et al. (+5)
12 [GO] 2022―May―01 Effects of Drugs Formerly Proposed for COVID-19 Treatment on Connexin43 Hemichannels Axelle Cooreman, Anne Caufriez, Andrés Tabernilla, Raf Van Campenhout, Kaat Leroy, Prashant Kadam, et al. (+4)
13 [GO] 2022―Apr―30 Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy Manuel Serrano, Gerard Espinosa, Antonio Serrano, Ricard Cervera
14 [GO] 2022―Apr―30 Molecular Dynamics Studies on the Structural Stability Prediction of SARS-CoV-2 Variants Including Multiple Mutants Kwang-Eun Choi, Jeong-Min Kim, Jee Eun Rhee, Ae Kyung Park, Eun-Jin Kim, Cheon Kwon Yoo, Nam Sook Kang
15 [GO] 2022―Apr―28 Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method Rolf Teschke, Nahum Méndez-Sánchez, Axel Eickhoff
16 [GO] 2022―Apr―28 Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19 Georgios Kassianidis, Athanasios Siampanos, Garyphalia Poulakou, George Adamis, Aggeliki Rapti, Haralampos Milionis, et al. (+8)
17 [GO] 2022―Apr―28 Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity Hung-Chun Liao, Wan-Ling Wu, Chen-Yi Chiang, Min-Syuan Huang, Kuan-Yin Shen, Yu-Ling Huang, et al. (+4)
18 [GO] 2022―Apr―28 Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients Martina Fabris, Fabio Del Ben, Emanuela Sozio, Antonio Paolo Beltrami, Adriana Cifé, Giacomo Bertolino, et al. (+4)
19 [GO] 2022―Apr―27 Anti-Inflammatory Effects and Decreased Formation of Neutrophil Extracellular Traps by Enoxaparin in COVID-19 Patients Supichcha Saithong, Wilasinee Saisorn, Punyot Tovichayathamrong, Grace Filbertine, Pattama Torvorapanit, Helen L. Wright, et al. (+4)
20 [GO] 2022―Apr―27 Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review Muhammed Majeed, Kalyanam Nagabhushanam, Priji Prakasan, Lakshmi Mundkur
21 [GO] 2022―Apr―21 Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm Paulina Niedźwiedzka-Rystwej, Adam Majchrzak, Sara Kurkowska, Paulina Małkowska, Olga Sierawska, Rafał Hrynkiewicz, Miłosz Parczewski
22 [GO] 2022―Apr―21 The Endolysosomal System: The Acid Test for SARS-CoV-2 Daniella Cesar-Silva, Filipe S. Pereira-Dutra, Ana Lucia Moraes Moraes Giannini, Cecília Jacques G. Jacques G. de Almeida
23 [GO] 2022―Apr―18 Computer Simulations and Network-Based Profiling of Binding and Allosteric Interactions of SARS-CoV-2 Spike Variant Complexes and the Host Receptor: Dissecting the Mechanistic Effects of the Delta and Omicron Mutations Gennady Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan
24 [GO] 2022―Apr―15 Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era Nicola Borbone, Ilaria Piccialli, Andrea Patrizia Falanga, Vincenzo Piccialli, Giovanni N. Roviello, Giorgia Oliviero
25 [GO] 2022―Apr―15 Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting Hui Xuan Lim, Malihe Masomian, Kanwal Khalid, Asqwin Uthaya Kumar, Paul A. MacAry, Chit Laa Poh
26 [GO] 2022―Apr―14 COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3? Renata Novak Kujundžić
27 [GO] 2022―Apr―13 Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
28 [GO] 2022―Apr―11 COVID-19 and One-Carbon Metabolism Joanna Perła-Kaján, Hieronim Jakubowski
29 [GO] 2022―Apr―11 Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body Marta Kopańska, Edyta Barnaś, Joanna Błajda, Barbara Kuduk, Anna Łagowska, Agnieszka Banaś-Ząbczyk
30 [GO] 2022―Apr―10 Theophylline: Old Drug in a New Light, Application in COVID-19 through Computational Studies Luis Montaño, Bettina Sommer, Juan Gomez-Verjan, Genaro Morales-Paoli, Gema Ramírez-Salinas, Héctor Solís-Chagoyán, et al. (+7)
31 [GO] 2022―Apr―10 Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection Marcin Janecki, Michał Graczyk, Agata Anna Lewandowska, Łukasz Pawlak
32 [GO] 2022―Apr―09 SARS-CoV-2 Pandemic Tracing in Italy Highlights Lineages with Mutational Burden in Growing Subsets Angelo Boccia, Rossella Tufano, Veronica Ferrucci, Leandra Sepe, Martina Bianchi, Stefano Pascarella, et al. (+2)
33 [GO] 2022―Apr―08 SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin-Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias towards Individuals with Pre-Diabetes/Type 2 Diabetes and Metabolic Diseases Jason Iles, Raminta Zmuidinaite, Christoph Sadee, Anna Gardiner, Jonathan Lacey, Stephen Harding, et al. (+5)
34 [GO] 2022―Apr―06 Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2 Richard Kuan-Lin Lee, Tian-Neng Li, Sui-Yuan Chang, Tai-Ling Chao, Chun-Hsien Kuo, Max Yu-Chen Pan, et al. (+8)
35 [GO] 2022―Apr―06 Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia Fabio Fais, Reda Juskeviciene, Veronica Francardo, Stéphanie Mateos, Manuela Guyard, Cécile Viollet, et al. (+3)
36 [GO] 2022―Apr―06 In Vitro SARS-CoV-2 Infection of Microvascular Endothelial Cells: Effect on Pro-Inflammatory Cytokine and Chemokine Release Maria Dolci, Lucia Signorini, Sarah D’Alessandro, Federica Perego, Silvia Parapini, Michele Sommariva, et al. (+4)
37 [GO] 2022―Apr―03 Swine Enteric Coronavirus: Diverse Pathogen-Host Interactions Quanhui Yan, Xiaodi Liu, Yawei Sun, Weijun Zeng, Yuwan Li, Feifan Zhao, et al. (+5)
38 [GO] 2022―Apr―03 In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking Luis Heriberto Vázquez-Mendoza, Humberto L. Mendoza-Figueroa, Juan Benjamín García-Vázquez, José Correa-Basurto, Jazmín García-Machorro
39 [GO] 2022―Mar―31 Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19 Mohamed Mahdi, Levente Hermán, János M. Réthelyi, Bálint László Bálint
40 [GO] 2022―Mar―30 Host and Viral Zinc-Finger Proteins in COVID-19 Sabrina Esposito, Gianluca D’Abrosca, Anna Antolak, Paolo Vincenzo Pedone, Carla Isernia, Gaetano Malgieri
41 [GO] 2022―Mar―30 SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability Tiziana Casoli
42 [GO] 2022―Mar―28 Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications Ching-Tse Ting, Bor-Sen Chen
43 [GO] 2022―Mar―28 What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection? Monika Gudowska-Sawczuk, Barbara Mroczko
44 [GO] 2022―Mar―28 The Role of Vitamin D in Supporting Health in the COVID-19 Era Alice Albergamo, Giulia Apprato, Francesca Silvagno
45 [GO] 2022―Mar―23 Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease János András Mótyán, Mohamed Mahdi, Gyula Hoffka, József Tőzsér
46 [GO] 2022―Mar―22 The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2 Gary Thomas, Frédéric Couture, Anna Kwiatkowska
47 [GO] 2022―Mar―22 Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19 Mariarita Brancaccio, Cristina Mennitti, Mariella Calvanese, Alessandro Gentile, Roberta Musto, Giulia Gaudiello, et al. (+7)
48 [GO] 2022―Mar―21 Artificial Intelligence Technologies for COVID-19 De Novo Drug Design Giuseppe Floresta, Chiara Zagni, Davide Gentile, Vincenzo Patamia, Antonio Rescifina
49 [GO] 2022―Mar―21 Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination Shinya Yamada, Hidesaku Asakura
50 [GO] 2022―Mar―21 SARS-CoV-2 Associated Immune Dysregulation and COVID-Associated Pulmonary Aspergilliosis (CAPA): A Cautionary Tale Dominic Adam Worku
51 [GO] 2022―Mar―21 High-Integrity Sequencing of Spike Gene for SARS-CoV-2 Variant Determination Yu-Chieh Liao, Feng-Jui Chen, Min-Chieh Chuang, Han-Chieh Wu, Wan-Chen Ji, Guann-Yi Yu, Tsi-Shu Huang
52 [GO] 2022―Mar―21 SARS-CoV-2 Spike Protein and Mouse Coronavirus Inhibit Biofilm Formation by Streptococcus pneumoniae and Staphylococcus aureus Mun Fai Loke, Indresh Yadav, Teck Kwang Lim, Johan R. C. van der Maarel, Lok-To Sham, Vincent T. Chow
53 [GO] 2022―Mar―21 SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro Zhengcun Wu, Xiuao Zhang, Zhangqiong Huang, Kaili Ma
54 [GO] 2022―Mar―16 An Upgrade on the Surveillance System of SARS-CoV-2: Deployment of New Methods for Genetic Inspection José Francisco Muñoz-Valle, Alberto Antony Venancio-Landeros, Rocío Sánchez-Sánchez, Karen Reyes-Díaz, Byron Galindo-Ornelas, Wendy Susana Hérnandez-Monjaraz, et al. (+8)
55 [GO] 2022―Mar―14 Neuroinflammation and COVID-19 Ischemic Stroke Recovery-Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1-7)/Mas Receptor Axis and NLRP3 Inflammasome Che Mohd Nasril Che Mohd Nassir, Mohd K. I. Zolkefley, Muhammad Danial Ramli, Haziq Hazman Norman, Hafizah Abdul Hamid, Muzaimi Mustapha
56 [GO] 2022―Mar―11 On the Efficacy of ZnO Nanostructures against SARS-CoV-2 Maria Chiara Sportelli, Margherita Izzi, Daniela Loconsole, Anna Sallustio, Rosaria Anna Picca, Roberto Felici, et al. (+2)
57 [GO] 2022―Mar―10 Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins Ana Tajuelo, Mireia López-Siles, Vicente Más, Pilar Pérez-Romero, José María Aguado, Verónica Briz, et al. (+3)
58 [GO] 2022―Mar―10 SARS-CoV-2 Membrane Protein: From Genomic Data to Structural New Insights Catarina Marques-Pereira, Manuel N. Pires, Raquel P. Gouveia, Nádia N. Pereira, Ana B. Caniceiro, Nícia Rosário-Ferreira, Irina S. Moreira
59 [GO] 2022―Mar―08 Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering Gennady Verkhivker
60 [GO] 2022―Mar―07 Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672 Concetta Cafiero, Alessandra Micera, Agnese Re, Beniamino Schiavone, Giulio Benincasa, Raffaele Palmirotta
61 [GO] 2022―Mar―07 Reply to Cafiero et al. Comment on “Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672” Marta Kopańska, Jacek Szczygielski, Paulina Bartman, Agnieszka Banaś-Ząbczyk
62 [GO] 2022―Mar―07 An Overview of Systematic Reviews of the Role of Vitamin D on Inflammation in Patients with Diabetes and the Potentiality of Its Application on Diabetic Patients with COVID-19 Christiano Argano, Raffaella Mallaci Bocchio, Marika Lo Monaco, Salvatore Scibetta, Giuseppe Natoli, Attilio Cavezzi, et al. (+2)
63 [GO] 2022―Mar―01 COVID-19 Pandemic: Escape of Pathogenic Variants and MHC Evolution Pierre Pontarotti, Julien Paganini
64 [GO] 2022―Mar―01 Malnutrition and Dietary Habits Alter the Immune System Which May Consequently Influence SARS-CoV-2 Virulence: A Review Ashmika Foolchand, Terisha Ghazi, Anil A. Chuturgoon
65 [GO] 2022―Feb―28 Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity Mohamed Haddad, Roger Gaudreault, Gabriel Sasseville, Phuong Trang Nguyen, Hannah Wiebe, Theo Van De Ven, et al. (+3)
66 [GO] 2022―Feb―25 A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody David E. Scheim
67 [GO] 2022―Feb―23 COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19 Michele Costanzo, Marianna Caterino, Roberta Fedele, Armando Cevenini, Mariarca Pontillo, Lucia Barra, Margherita Ruoppolo
68 [GO] 2022―Feb―23 Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract Yuan Zhang, Juhura G. Almazi, Hui Xin Ong, Matt D. Johansen, Scott Ledger, Daniela Traini, et al. (+3)
69 [GO] 2022―Feb―22 Immunomodulatory and Anti-Inflammatory Properties of Selenium-Containing Agents: Their Role in the Regulation of Defense Mechanisms against COVID-19 Valentina N. Mal’tseva, Michael V. Goltyaev, Egor A. Turovsky, Elena G. Varlamova
70 [GO] 2022―Feb―22 Discovery of SARS-CoV-2 3CLPro Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein-Ligand Interactions Yaxin Wang, Binghong Xu, Sen Ma, Hao Wang, Luqing Shang, Cheng Zhu, Sheng Ye
71 [GO] 2022―Feb―18 Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms, and Potential Therapeutic Targets J. Pedro Teixeira, Sharon Barone, Kamyar Zahedi, Manoocher Soleimani
72 [GO] 2022―Feb―18 Molecular and Cellular Mechanisms of M. tuberculosis and SARS-CoV-2 Infections-Unexpected Similarities of Pathogenesis and What to Expect from Co-Infection Anna A. Starshinova, Igor Kudryavtsev, Anna Malkova, Ulia Zinchenko, Vadim Karev, Dmitry Kudlay, et al. (+6)
73 [GO] 2022―Feb―17 Implication of COVID-19 on Erythrocytes Functionality: Red Blood Cell Biochemical Implications and Morpho-Functional Aspects Annamaria Russo, Ester Tellone, Davide Barreca, Silvana Ficarra, Giuseppina Laganà
74 [GO] 2022―Feb―17 Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice Mariya B. Borgoyakova, Larisa I. Karpenko, Andrey P. Rudometov, Ekaterina A. Volosnikova, Iuliia A. Merkuleva, Ekaterina V. Starostina, et al. (+15)
75 [GO] 2022―Feb―17 Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant Gennady Verkhivker
76 [GO] 2022―Feb―15 Exploring Mitochondrial Localization of SARS-CoV-2 RNA by Padlock Assay: A Pilot Study in Human Placenta Francesca Gabanella, Christian Barbato, Nicoletta Corbi, Marco Fiore, Carla Petrella, Marco de Vincentiis, et al. (+11)
77 [GO] 2022―Feb―14 Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review Giorgio Tiecco, Samuele Storti, Melania Degli Antoni, Emanuele Focà, Francesco Castelli, Eugenia Quiros-Roldan
78 [GO] 2022―Feb―14 Analysis of the Neutralizing Activity of Antibodies Targeting Open or Closed SARS-CoV-2 Spike Protein Conformations Gabriel Cia, Fabrizio Pucci, Marianne Rooman
79 [GO] 2022―Feb―10 Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients-A Target for SARS-CoV-2 Propagation Veronica Ferrucci, Pasqualino de Antonellis, Fabrizio Quarantelli, Fatemeh Asadzadeh, Francesca Bibbò, Roberto Siciliano, et al. (+25)
80 [GO] 2022―Feb―09 AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome Clovis Chabert, Anne-Laure Vitte, Domenico Iuso, Florent Chuffart, Candice Trocme, Marlyse Buisson, et al. (+7)
81 [GO] 2022―Feb―07 Mechanism of Caspase-1 Inhibition by Four Anti-inflammatory Drugs Used in COVID-19 Treatment Francesco Caruso, Jens Z. Pedersen, Sandra Incerpi, Sarjit Kaur, Stuart Belli, Radu-Mihai Florea, Miriam Rossi
82 [GO] 2022―Feb―04 Identification of Potential Antiviral Inhibitors from Hydroxychloroquine and 1,2,4,5-Tetraoxanes Analogues and Investigation of the Mechanism of Action in SARS-CoV-2 Ryan S. Ramos, Rosivaldo S. Borges, João S. N. de Souza, Inana F. Araujo, Mariana H. Chaves, Cleydson B. R. Santos
83 [GO] 2022―Feb―04 Molecular Docking and Molecular Dynamics Simulations Discover Curcumin Analogue as a Plausible Dual Inhibitor for SARS-CoV-2 Shailima Rampogu, Gihwan Lee, Jun Sung Park, Keun Woo Lee, Myeong Ok Kim
84 [GO] 2022―Feb―03 Sars-Cov-2-Specific Immune Response and the Pathogenesis of COVID-19 Evgenii Gusev, Alexey Sarapultsev, Liliya Solomatina, Valeriy Chereshnev
85 [GO] 2022―Feb―03 COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway Seigo Nagashima, Anderson Azevedo Dutra, Mayara Pezzini Arantes, Rafaela Chiuco Zeni, Carolline Konzen Klein, Flávia Centenaro de Oliveira, et al. (+11)
86 [GO] 2022―Feb―01 A Multi-Disulfide Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Protein Expressed in E. coli Using a SEP-Tag Produces Antisera Interacting with the Mammalian Cell Expressed Spike (S1) Protein  Subbaian Brindha, Yutaka Kuroda
87 [GO] 2022―Jan―31 Conformational Flexibility and Local Frustration in the Functional States of the SARS-CoV-2 Spike B.1.1.7 and B.1.351 Variants: Mutation-Induced Allosteric Modulation Mechanism of Functional Dynamics and Protein Stability Gennady Verkhivker
88 [GO] 2022―Jan―30 Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19 Jan C. Kamp, Lavinia Neubert, Maximilian Ackermann, Helge Stark, Christopher Werlein, Jan Fuge, et al. (+11)
89 [GO] 2022―Jan―30 The “Elastic Perspective” of SARS-CoV-2 Infection and the Role of Intrinsic and Extrinsic Factors Federica Boraldi, Francesco Demetrio Lofaro, Andrea Cossarizza, Daniela Quaglino
90 [GO] 2022―Jan―28 Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects Agnieszka Drozdzik, Marek Drozdzik
91 [GO] 2022―Jan―26 The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment Lukas Wettstein, Frank Kirchhoff, Jan Münch
92 [GO] 2022―Jan―26 Aptamers-Diagnostic and Therapeutic Solution in SARS-CoV-2 Tomasz Wandtke, Ewelina Wędrowska, Marcin Szczur, Grzegorz Przybylski, Marek Libura, Piotr Kopiński
93 [GO] 2022―Jan―26 RT-qPCR Detection of SARS-CoV-2: No Need for a Dedicated Reverse Transcription Step Stephen A. Bustin, Gregory L. Shipley, Sara Kirvell, Reinhold Mueller, Tania Nolan
94 [GO] 2022―Jan―24 Meta-Analysis of APP Expression Modulated by SARS-CoV-2 Infection via the ACE2 Receptor Alyssa Caradonna, Tanvi Patel, Matea Toleska, Sedra Alabed, Sulie L. Chang
95 [GO] 2022―Jan―19 Secondary Structures of the Transmembrane Domain of SARS-CoV-2 Spike Protein in Detergent Micelles Qingxin Li, Qiwei Huang, Congbao Kang
96 [GO] 2022―Jan―19 Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection Natasja de Bruin, Ann-Kathrin Schneider, Philipp Reus, Sonja Talmon, Sandra Ciesek, Denisa Bojkova, et al. (+9)
97 [GO] 2022―Jan―17 Could Lower Testosterone in Older Men Explain Higher COVID-19 Morbidity and Mortalities? Luis M. Montaño, Bettina Sommer, Héctor Solís-Chagoyán, Bianca S. Romero-Martínez, Arnoldo Aquino-Gálvez, Juan C. Gomez-Verjan, et al. (+3)
98 [GO] 2022―Jan―14 Consequences of COVID-19 for the Pancreas Urszula Abramczyk, Maciej Nowaczyński, Adam Słomczyński, Piotr Wojnicz, Piotr Zatyka, Aleksandra Kuzan
99 [GO] 2022―Jan―13 Computational Design of Miniproteins as SARS-CoV-2 Therapeutic Inhibitors Bahaa Jawad, Puja Adhikari, Kun Cheng, Rudolf Podgornik, Wai-Yim Ching
100 [GO] 2022―Jan―13 Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection Bang M. Tran, Samantha L. Grimley, Julie L. McAuley, Abderrahman Hachani, Linda Earnest, Sharon L. Wong, et al. (+11)
101 [GO] 2022―Jan―12 Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission Anett Hudák, Gábor Veres, Annamária Letoha, László Szilák, Tamás Letoha
102 [GO] 2022―Jan―10 Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research Marta Kopańska, Marta Batoryna, Paulina Bartman, Jacek Szczygielski, Agnieszka Banaś-Ząbczyk
103 [GO] 2022―Jan―10 Biosensors for the Determination of SARS-CoV-2 Virus and Diagnosis of COVID-19 Infection Maryia Drobysh, Almira Ramanaviciene, Roman Viter, Chien-Fu Chen, Urte Samukaite-Bubniene, Vilma Ratautaite, Arunas Ramanavicius
104 [GO] 2022―Jan―10 COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives Marianne Lauwers, Manting Au, Shuofeng Yuan, Chunyi Wen
105 [GO] 2022―Jan―07 Synthesis of Nucleoside-like Molecules from a Pyrolysis Product of Cellulose and Their Computational Prediction as Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors Andrea Defant, Federico Dosi, Nicole Innocenti, Ines Mancini
106 [GO] 2022―Jan―07 Glycosylation of Receptor Binding Domain of SARS-CoV-2 S-Protein Influences on Binding to Immobilized DNA Aptamers Fedor Grabovenko, Liudmila Nikiforova, Bogdan Yanenko, Andrey Ulitin, Eugene Loktyushov, Timofei Zatsepin, et al. (+2)
107 [GO] 2021―Dec―31 Commercial SARS-CoV-2 Targeted, Protease Inhibitor Focused and Protein-Protein Interaction Inhibitor Focused Molecular Libraries for Virtual Screening and Drug Design Sebastjan Kralj, Marko Jukič, Urban Bren
108 [GO] 2021―Dec―28 Role of Selenium in Viral Infections with a Major Focus on SARS-CoV-2 Sabrina Sales Martinez, Yongjun Huang, Leonardo Acuna, Eduardo Laverde, David Trujillo, Manuel A. Barbieri, et al. (+3)
109 [GO] 2021―Dec―28 A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet? Guillem Macip, Pol Garcia-Segura, Júlia Mestres-Truyol, Bryan Saldivar-Espinoza, Gerard Pujadas, Santiago Garcia-Vallvé
110 [GO] 2021―Dec―28 Exploring the Catalytic Mechanism of the RNA Cap Modification by nsp16-nsp10 Complex of SARS-CoV-2 through a QM/MM Approach José Rogério A. Silva, Jaime Urban, Edson Araújo, Jerônimo Lameira, Vicent Moliner, Cláudio Nahum Alves
111 [GO] 2021―Dec―24 COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis Caroline Busatta Vaz de Vaz de Paula, Seigo Nagashima, Vanessa Liberalesso, Mariana Collete, Felipe Paes Gomes da da Silva, Alessandro Gonçalves Gomes Oricil, et al. (+5)
112 [GO] 2021―Dec―22 Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients Pierre-Jean Ferron, Brendan Le Daré, Julie Bronsard, Clara Steichen, Elodie Babina, Romain Pelletier, et al. (+7)
113 [GO] 2021―Dec―22 Protective Effects of Meldonium in Experimental Models of Cardiovascular Complications with a Potential Application in COVID-19 Reinis Vilskersts, Dana Kigitovica, Stanislava Korzh, Melita Videja, Karlis Vilks, Helena Cirule, et al. (+4)
114 [GO] 2021―Dec―21 Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review Daniele Focosi, Fabrizio Maggi, Massimo Franchini, Scott McConnell, Arturo Casadevall
115 [GO] 2021―Dec―20 Mechanism of Blood-Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury Rubens P. Homme, Akash K. George, Mahavir Singh, Irina Smolenkova, Yuting Zheng, Sathnur Pushpakumar, Suresh C. Tyagi
116 [GO] 2021―Dec―20 SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer’s Disease Patients Luigi Chiricosta, Agnese Gugliandolo, Emanuela Mazzon
117 [GO] 2021―Dec―20 Entrectinib-A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells Alejandro Peralta-Garcia, Mariona Torrens-Fontanals, Tomasz Maciej Stepniewski, Judith Grau-Expósito, David Perea, Vikram Ayinampudi, et al. (+5)
118 [GO] 2021―Dec―20 Prothrombotic Phenotype in COVID-19: Focus on Platelets Cristina Barale, Elena Melchionda, Alessandro Morotti, Isabella Russo
119 [GO] 2021―Dec―15 Protein-Based Nanoparticle Vaccines for SARS-CoV-2 Hyo-Dong Sung, Nayeon Kim, Yeram Lee, Eun Jung Lee
120 [GO] 2021―Dec―10 Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta Maria Fröba, Maximilian Große, Christian Setz, Pia Rauch, Janina Auth, Lucas Spanaus, et al. (+8)
121 [GO] 2021―Dec―07 MicroRNA-Mediated Regulation of the Virus Cycle and Pathogenesis in the SARS-CoV-2 Disease Rosalia Battaglia, Ruben Alonzo, Chiara Pennisi, Angela Caponnetto, Carmen Ferrara, Michele Stella, et al. (+5)
122 [GO] 2021―Dec―01 Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19 Taylor Morganstein, Zahraa Haidar, Joshua Trivlidis, Ilan Azuelos, Megan Jiaxin Huang, David H. Eidelman, Carolyn J. Baglole
123 [GO] 2021―Dec―01 Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19 Tomas Rajtik, Peter Galis, Linda Bartosova, Ludovit Paulis, Eva Goncalvesova, Jan Klimas
124 [GO] 2021―Nov―30 Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19 Fahadul Islam, Shabana Bibi, Atkia Farzana Khan Meem, Md. Mohaimenul Islam, Md. Saidur Rahaman, Sristy Bepary, et al. (+9)
125 [GO] 2021―Nov―30 Non-Woven Infection Prevention Fabrics Coated with Biobased Cranberry Extracts Inactivate Enveloped Viruses Such as SARS-CoV-2 and Multidrug-Resistant Bacteria Kazuo Takayama, Alberto Tuñón-Molina, Alba Cano-Vicent, Yukiko Muramoto, Takeshi Noda, José Luis Aparicio-Collado, et al. (+3)
126 [GO] 2021―Nov―22 How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19 Ludmila Müller, Svetlana Di Benedetto
127 [GO] 2021―Nov―19 Chemical Exposures Affect Innate Immune Response to SARS-CoV-2 Olatunbosun Arowolo, Leonid Pobezinsky, Alexander Suvorov
128 [GO] 2021―Nov―18 Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19 Ruei-Min Lu, Shih-Han Ko, Wan-Yu Chen, Yu-Ling Chang, Hsiu-Ting Lin, Han-Chung Wu
129 [GO] 2021―Nov―17 Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention Nikola Gligorijevic, Mirjana Radomirovic, Olgica Nedic, Marija Stojadinovic, Urmila Khulal, Dragana Stanic-Vucinic, Tanja Cirkovic Velickovic
130 [GO] 2021―Nov―15 Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues Ali A. Rizvi, Andrej Janez, Manfredi Rizzo
131 [GO] 2021―Nov―12 SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad Lucia Natarelli, Fabio Virgili, Christian Weber
132 [GO] 2021―Nov―10 Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease Yuxi Lin, Ruochen Zang, Yanlong Ma, Zhuoya Wang, Li Li, Siyuan Ding, et al. (+4)
133 [GO] 2021―Nov―09 SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape Lin Yang, Jiacheng Li, Shuai Guo, Chengyu Hou, Chenchen Liao, Liping Shi, et al. (+6)
134 [GO] 2021―Nov―08 An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review Chiara Stassi, Cristina Mondello, Gennaro Baldino, Luigi Cardia, Alessio Asmundo, Elvira Ventura Spagnolo
135 [GO] 2021―Nov―08 Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications Yasutomi Higashikuni, Wenhao Liu, Takumi Obana, Masataka Sata
136 [GO] 2021―Nov―04 A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19 Syed Mohammed Basheeruddin Asdaq, Syed Imam Rabbani, Meshary Alkahtani, Meshal Meshary Aldohyan, Abdullah Mohammad Alabdulsalam, Majed Sadun Alshammari, et al. (+7)
137 [GO] 2021―Nov―03 The Role of Endothelium in COVID-19 Mihaela Ionescu, Anca Pantea Stoian, Manfredi Rizzo, Dragos Serban, Domenico Nuzzo, Laura Mazilu, et al. (+3)
138 [GO] 2021―Nov―02 A Review on the Role of Stem Cells against SARS-CoV-2 in Children and Pregnant Women Fatemeh Sanie-Jahromi, Yaser NejatyJahromy, Rahim Raoofi Jahromi
139 [GO] 2021―Nov―02 Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro Rai C. Silva, Humberto F. Freitas, Joaquín M. Campos, Njogu M. Kimani, Carlos H. T. P. Silva, Rosivaldo S. Borges, et al. (+2)
140 [GO] 2021―Nov―02 25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses Qiaoshuai Lan, Chao Wang, Jie Zhou, Lijue Wang, Fanke Jiao, Yanbo Zhang, et al. (+4)
141 [GO] 2021―Nov―02 SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes Andrea Valeri, Luigi Chiricosta, Agnese Gugliandolo, Mara Biasin, Maria Antonietta Avanzini, Valeria Calcaterra, et al. (+6)
142 [GO] 2021―Nov―02 Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L Elisa Costanzi, Maria Kuzikov, Francesca Esposito, Simone Albani, Nicola Demitri, Barbara Giabbai, et al. (+5)
143 [GO] 2021―Oct―29 Whey-Derived Peptides at the Heart of the COVID-19 Pandemic Yara Chamata, Kim G. Jackson, Kimberly A. Watson, Paula Jauregi
144 [GO] 2021―Oct―29 Establishment of a Rapid Detection System for ISG20-Dependent SARS-CoV-2 Subreplicon RNA Degradation Induced by Interferon-α Yutaka Furutani, Mariko Toguchi, Shoko Higuchi, Kaori Yanaka, Luc Gailhouste, Xian-Yang Qin, et al. (+3)
145 [GO] 2021―Oct―28 A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD-ACE2 Interaction Narcis Fernandez-Fuentes, Ruben Molina, Baldo Oliva
146 [GO] 2021―Oct―28 Infection of Brain Pericytes Underlying Neuropathology of COVID-19 Patients Matteo Bocci, Clara Oudenaarden, Xavier Sàenz-Sardà, Joel Simrén, Arvid Edén, Jonas Sjölund, et al. (+5)
147 [GO] 2021―Oct―27 Structural and Functional Analysis of Female Sex Hormones against SARS-CoV-2 Cell Entry Jorge Alberto Aguilar-Pineda, Mazen Albaghdadi, Wanlin Jiang, Karin J. Vera-Lopez, Rita Nieto-Montesinos, Karla Lucia F. Alvarez, et al. (+5)
148 [GO] 2021―Oct―26 Metabolic Reprogramming in COVID-19 Tao Shen, Tingting Wang
149 [GO] 2021―Oct―26 Pituitary-Adrenal Responses and Glucocorticoid Receptor Expression in Critically Ill Patients with COVID-19 Dimitra A. Vassiliadi, Alice G. Vassiliou, Ioannis Ilias, Stylianos Tsagarakis, Anastasia Kotanidou, Ioanna Dimopoulou
150 [GO] 2021―Oct―26 ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review Lihua Qu, Chao Chen, Tong Yin, Qian Fang, Zizhan Hong, Rui Zhou, et al. (+2)
151 [GO] 2021―Oct―20 Alveolar Regeneration in COVID-19 Patients: A Network Perspective Shishir K. Gupta, Mugdha Srivastava, Rashmi Minocha, Aman Akash, Seema Dangwal, Thomas Dandekar
152 [GO] 2021―Oct―18 Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19 Panagiotis Theofilis, Marios Sagris, Alexios S. Antonopoulos, Evangelos Oikonomou, Costas Tsioufis, Dimitris Tousoulis
153 [GO] 2021―Oct―18 Potential Novel Thioether-Amide or Guanidine-Linker Class of SARS-CoV-2 Virus RNA-Dependent RNA Polymerase Inhibitors Identified by High-Throughput Virtual Screening Coupled to Free-Energy Calculations Marko Jukič, Dušanka Janežič, Urban Bren
154 [GO] 2021―Oct―14 Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications Prakash Patil, Praveenkumar Shetty, Nithin Kuriakose, Pavan Gollapalli, Sukanya Shetty, Roopa Bhandary, et al. (+2)
155 [GO] 2021―Oct―14 Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review Ridhima Kaul, Pradipta Paul, Sanjay Kumar, Dietrich Büsselberg, Vivek Dhar Dwivedi, Ali Chaari
156 [GO] 2021―Oct―11 Successful Treatment of Persistent SARS-CoV-2 Infection in a B-Cell Depleted Patient with Activated Cytotoxic T and NK Cells: A Case Report Jacek Jassem, Natalia Maria Marek-Trzonkowska, Tomasz Smiatacz, Łukasz Arcimowicz, Ines Papak, Ewa Jassem, Jan Maciej Zaucha
157 [GO] 2021―Oct―11 Receptor-Loaded Virion Endangers GPCR Signaling: Mechanistic Exploration of SARS-CoV-2 Infections and Pharmacological Implications Qiangmin Zhang, Peter A. Friedman
158 [GO] 2021―Oct―09 SARS-CoV-2 Virus-Host Interaction: Currently Available Structures and Implications of Variant Emergence on Infectivity and Immune Response Luís Queirós-Reis, Priscilla Gomes da Silva, José Gonçalves, Andrea Brancale, Marcella Bassetto, João R. Mesquita
159 [GO] 2021―Oct―07 Establishment of Intestinal Organoid from Rousettus leschenaultii and the Susceptibility to Bat-Associated Viruses, SARS-CoV-2 and Pteropine Orthoreovirus Mohamed Elbadawy, Yuki Kato, Nagisa Saito, Kimika Hayashi, Amira Abugomaa, Mio Kobayashi, et al. (+10)
160 [GO] 2021―Oct―07 Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways Ralf Kircheis
161 [GO] 2021―Oct―04 Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations Rafat Zrieq, Iqrar Ahmad, Mejdi Snoussi, Emira Noumi, Marcello Iriti, Fahad D. Algahtani, et al. (+6)
162 [GO] 2021―Oct―01 The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection Nadine Krüger, Cheila Rocha, Sandra Runft, Johannes Krüger, Iris Färber, Federico Armando, et al. (+6)
163 [GO] 2021―Sep―30 Vitamin D and COVID-19: An Overview of Recent Evidence Drishti Ghelani, Simon Alesi, Aya Mousa
164 [GO] 2021―Sep―29 Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites Faisal A. Alzahrani, Mohammed Razeeth Shait Mohammed, Saleh Alkarim, Esam I. Azhar, Mohammed A. El-Magd, Yousef Hawsawi, et al. (+10)
165 [GO] 2021―Sep―29 Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis Serge Nataf, Laurent Pays
166 [GO] 2021―Sep―29 The Crosstalk between SARS-CoV-2 Infection and the RAA System in Essential Hypertension-Analyses Using Systems Approach Dorota Formanowicz, Kaja Gutowska, Bartłomiej Szawulak, Piotr Formanowicz
167 [GO] 2021―Sep―27 The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure Ruth P. Duecker, Elisabeth H. Adam, Sarah Wirtz, Lucia Gronau, Yascha Khodamoradi, Fabian J. Eberhardt, et al. (+8)
168 [GO] 2021―Sep―27 Good Cholesterol Gone Bad? HDL and COVID-19 George E. G. Kluck, Jeong-Ah Yoo, Emmanuel H. Sakarya, Bernardo L. Trigatti
169 [GO] 2021―Sep―27 Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination Alexandra Herrmann, Doris Jungnickl, Arne Cordsmeier, Antonia Sophia Peter, Klaus Überla, Armin Ensser
170 [GO] 2021―Sep―25 Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature Enrica Torretta, Micaela Garziano, Mariacristina Poliseno, Daniele Capitanio, Mara Biasin, Teresa Antonia Santantonio, et al. (+4)
171 [GO] 2021―Sep―23 Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta Janina Auth, Maria Fröba, Maximilian Große, Pia Rauch, Natalia Ruetalo, Michael Schindler, et al. (+6)
172 [GO] 2021―Sep―17 Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells Ioanna Nikitopoulou, Dionysios Fanidis, Konstantinos Ntatsoulis, Panagiotis Moulos, George Mpekoulis, Maria Evangelidou, et al. (+12)
173 [GO] 2021―Sep―17 Vitamin D and Platelets: A Menacing Duo in COVID-19 and Potential Relation to Bone Remodeling Francesca Salamanna, Melania Maglio, Maria Sartori, Maria Paola Landini, Milena Fini
174 [GO] 2021―Sep―14 Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes Chiu-Yang Lee, Chih-Heng Huang, Elham Rastegari, Vimalan Rengganaten, Ping-Cheng Liu, Ping-Hsing Tsai, et al. (+12)
175 [GO] 2021―Sep―13 Virtual Alanine Scan of the Main Protease Active Site in Severe Acute Respiratory Syndrome Coronavirus 2 Tomoki Nakayoshi, Koichi Kato, Eiji Kurimoto, Akifumi Oda
176 [GO] 2021―Sep―10 The Se-S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study Angela Parise, Isabella Romeo, Nino Russo, Tiziana Marino
177 [GO] 2021―Sep―09 Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19 Samar Rezq, Alexandra M. Huffman, Jelina Basnet, Licy L. Yanes Cardozo, Damian G. Romero
178 [GO] 2021―Sep―07 Computational Methods to Study Human Transcript Variants in COVID-19 Infected Lung Cancer Cells Jiao Sun, Naima Ahmed Fahmi, Heba Nassereddeen, Sze Cheng, Irene Martinez, Deliang Fan, et al. (+2)
179 [GO] 2021―Sep―06 Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients Marta Karaźniewicz-Łada, Anna K. Główka, Aniceta A. Mikulska, Franciszek K. Główka
180 [GO] 2021―Sep―02 The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism Marianna Caterino, Michele Costanzo, Roberta Fedele, Armando Cevenini, Monica Gelzo, Alessandro Di Minno, et al. (+14)
181 [GO] 2021―Sep―02 Antimicrobial Face Shield: Next Generation of Facial Protective Equipment against SARS-CoV-2 and Multidrug-Resistant Bacteria Alberto Tuñón-Molina, Miguel Martí, Yukiko Muramoto, Takeshi Noda, Kazuo Takayama, Ángel Serrano-Aroca
182 [GO] 2021―Aug―31 Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Darius Riziki Martin, Ashwil Klein, Abram Madiehe, Mervin Meyer
183 [GO] 2021―Aug―31 Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation Simone Di Micco, Simona Musella, Marina Sala, Maria C. Scala, Graciela Andrei, Robert Snoeck, et al. (+3)
184 [GO] 2021―Aug―27 Epigenetic Clocks Are Not Accelerated in COVID-19 Patients Julia Franzen, Selina Nüchtern, Vithurithra Tharmapalan, Margherita Vieri, Miloš Nikolić, Yang Han, et al. (+7)
185 [GO] 2021―Aug―26 SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues Guoshuai Cai, Mulong Du, Yohan Bossé, Helmut Albrecht, Fei Qin, Xizhi Luo, et al. (+8)
186 [GO] 2021―Aug―26 Phosphorylation of SARS-CoV-2 Orf9b Regulates Its Targeting to Two Binding Sites in TOM70 and Recruitment of Hsp90 Lukas Brandherm, Antonio Mario Kobaš, Mara Klöhn, Yannick Brüggemann, Stephanie Pfaender, Joachim Rassow, Sebastian Kreimendahl
187 [GO] 2021―Aug―26 The Role of the PFNA Operon of Bifidobacteria in the Recognition of Host’s Immune Signals: Prospects for the Use of the FN3 Protein in the Treatment of COVID-19 Venera Z. Nezametdinova, Roman A. Yunes, Marina S. Dukhinova, Maria G. Alekseeva, Valery N. Danilenko
188 [GO] 2021―Aug―25 Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity Vipul Kumar, Jasdeep Singh, Seyed E. Hasnain, Durai Sundar
189 [GO] 2021―Aug―25 Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations Bilal Ahmad, Maria Batool, Qurat ul Ain, Moon Suk Kim, Sangdun Choi
190 [GO] 2021―Aug―23 Putative Role of Vitamin D for COVID-19 Vaccination Sheng-Kang Chiu, Kuo-Wang Tsai, Chia-Chao Wu, Cai-Mei Zheng, Chung-Hsiang Yang, Wan-Chung Hu, et al. (+3)
191 [GO] 2021―Aug―23 SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites Guilherme C. Lechuga, Franklin Souza-Silva, Carolina Q. Sacramento, Monique R. O. Trugilho, Richard H. Valente, Paloma Napoleão-Pêgo, et al. (+9)
192 [GO] 2021―Aug―23 Cell-Free Hemoglobin Does Not Attenuate the Effects of SARS-CoV-2 Spike Protein S1 Subunit in Pulmonary Endothelial Cells Sirsendu Jana, Michael R. Heaven, Abdu I. Alayash
193 [GO] 2021―Aug―23 Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants Hsin-I Wang, Zih-Shiuan Chuang, Yu-Ting Kao, Yi-Ling Lin, Jian-Jong Liang, Chun-Che Liao, et al. (+3)
194 [GO] 2021―Aug―20 Adaptive Immunity and the Risk of Autoreactivity in COVID-19 Rhiane Moody, Kirsty Wilson, Katie L. Flanagan, Anthony Jaworowski, Magdalena Plebanski
195 [GO] 2021―Aug―20 “Molecular Masks” for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry Satya Prakash Shukla, Kwang Bog Cho, Vineeta Rustagi, Xiang Gao, Xinping Fu, Shaun Xiaoliu Zhang, et al. (+2)
196 [GO] 2021―Aug―18 Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease Monika Szturmowicz, Urszula Demkow
197 [GO] 2021―Aug―18 Oxidative Inactivation of SARS-CoV-2 on Photoactive AgNPs@TiO2 Ceramic Tiles Ridha Djellabi, Nicoletta Basilico, Serena Delbue, Sarah D’Alessandro, Silvia Parapini, Giuseppina Cerrato, et al. (+3)
198 [GO] 2021―Aug―18 Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia Sachiko Koyama, Kenji Kondo, Rumi Ueha, Hideki Kashiwadani, Thomas Heinbockel
199 [GO] 2021―Aug―18 Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery Maamoun Basheer, Elias Saad, Orly Laskar, Ofir Schuster, Hagai Rechnitzer, Simona Zisman-Rozen, et al. (+2)
200 [GO] 2021―Aug―13 Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2 Kwang-Eun Choi, Jeong-Min Kim, JeeEun Rhee, Ae Kyung Park, Eun-Jin Kim, Nam Sook Kang
201 [GO] 2021―Aug―13 RT-qPCR Diagnostics: The “Drosten” SARS-CoV-2 Assay Paradigm Stephen Bustin, Sara Kirvell, Jim F. Huggett, Tania Nolan
202 [GO] 2021―Aug―12 Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy Maria Narożna, Błażej Rubiś
203 [GO] 2021―Aug―12 SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection Niraj Lodhi, Rubi Singh, Satya Prakash Rajput, Quaiser Saquib
204 [GO] 2021―Aug―11 Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders Adam Wichniak, Aleksander Kania, Mariusz Siemiński, Wiesław Jerzy Cubała
205 [GO] 2021―Aug―10 Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor Young Soo Kim, Hwan-Suck Chung, Sang Gyun Noh, Bonggi Lee, Hae Young Chung, Jang-Gi Choi
206 [GO] 2021―Aug―09 Selenium Deficiency Due to Diet, Pregnancy, Severe Illness, or COVID-19-A Preventable Trigger for Autoimmune Disease Lutz Schomburg
207 [GO] 2021―Aug―09 Novel Nested-Seq Approach for SARS-CoV-2 Real-Time Epidemiology and In-Depth Mutational Profiling in Wastewater Margaritis Avgeris, Panagiotis G. Adamopoulos, Aikaterini Galani, Marieta Xagorari, Dimitrios Gourgiotis, Ioannis P. Trougakos, et al. (+4)
208 [GO] 2021―Aug―09 Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis Margherita Passariello, Cinzia Vetrei, Felice Amato, Claudia De Lorenzo
209 [GO] 2021―Aug―06 Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality Yadira Palacios, Andy Ruiz, Lucero Ramón-Luing, Ranferi Ocaña-Guzman, Omar Barreto-Rodriguez, Anahí Sánchez-Monciváis, et al. (+12)
210 [GO] 2021―Aug―02 Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID Samantha L. Cooper, Eleanor Boyle, Sophie R. Jefferson, Calum R. A. Heslop, Pirathini Mohan, Gearry G. J. Mohanraj, et al. (+4)
211 [GO] 2021―Jul―30 Mitochondrial Modulations, Autophagy Pathways Shifts in Viral Infections: Consequences of COVID-19 Shailendra Pratap Singh, Salomon Amar, Pinky Gehlot, Sanjib K. Patra, Navjot Kanwar, Abhinav Kanwal
212 [GO] 2021―Jul―30 The Effects of Aβ1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 John Tsu-An Hsu, Chih-Feng Tien, Guann-Yi Yu, Santai Shen, Yi-Hsuan Lee, Pei-Chien Hsu, et al. (+4)
213 [GO] 2021―Jul―28 Acute Kidney Injury in COVID-19 Marta Głowacka, Sara Lipka, Ewelina Młynarska, Beata Franczyk, Jacek Rysz
214 [GO] 2021―Jul―28 SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis Agnese Gugliandolo, Luigi Chiricosta, Valeria Calcaterra, Mara Biasin, Gioia Cappelletti, Stephana Carelli, et al. (+5)
215 [GO] 2021―Jul―27 The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19 Sonia Emanuele, Adriana Celesia, Antonella D’Anneo, Marianna Lauricella, Daniela Carlisi, Anna De Blasio, Michela Giuliano
216 [GO] 2021―Jul―27 Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection Luc Rochette, Steliana Ghibu
217 [GO] 2021―Jul―27 An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity Saioa Gómez-Zorita, Iñaki Milton-Laskibar, Laura García-Arellano, Marcela González, María P. Portillo
218 [GO] 2021―Jul―26 Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2 So Yeong Cheon, Bon-Nyeo Koo
219 [GO] 2021―Jul―26 Perspective of the Relationship between the Susceptibility to Initial SARS-CoV-2 Infectivity and Optimal Nasal Conditioning of Inhaled Air Ranjan Ramasamy
220 [GO] 2021―Jul―26 The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review Chiara Agrati, Alessandra Sacchi, Eleonora Tartaglia, Alessandra Vergori, Roberta Gagliardini, Alessandra Scarabello, Michele Bibas
221 [GO] 2021―Jul―26 Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin Srinu Tumpara, Anna R. Gründing, Kokilavani Sivaraman, Sabine Wrenger, Beata Olejnicka, Tobias Welte, et al. (+5)
222 [GO] 2021―Jul―21 Diabetic Nephropathy and COVID-19: The Potential Role of Immune Actors Diane Mourad, Nadim S. Azar, Sami T. Azar
223 [GO] 2021―Jul―19 Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells Cassio Luiz Coutinho Almeida-da-Silva, Harmony Matshik Dakafay, Kaitlyn Liu, David M. Ojcius
224 [GO] 2021―Jul―19 Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors Nedra Mekni, Claudia Coronnello, Thierry Langer, Maria De Rosa, Ugo Perricone
225 [GO] 2021―Jul―16 Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection Weronika Bielka, Agnieszka Przezak, Andrzej Pawlik
226 [GO] 2021―Jul―15 Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes) Evgenii Gusev, Alexey Sarapultsev, Desheng Hu, Valeriy Chereshnev
227 [GO] 2021―Jul―14 Extension of Collagen Deposition in COVID-19 Post Mortem Lung Samples and Computed Tomography Analysis Findings Lorenzo Ball, Emanuela Barisione, Luca Mastracci, Michela Campora, Delfina Costa, Chiara Robba, et al. (+8)
228 [GO] 2021―Jul―13 Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19 Morgane Ducastel, Camille Chenevier-Gobeaux, Yassine Ballaa, Jean-François Meritet, Michel Brack, Nicolas Chapuis, et al. (+6)
229 [GO] 2021―Jul―13 COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases Pier-Angelo Tovo, Silvia Garazzino, Valentina Daprà, Giulia Pruccoli, Cristina Calvi, Federica Mignone, et al. (+8)
230 [GO] 2021―Jul―13 Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain Divyendu Goud Thalla, Philipp Jung, Markus Bischoff, Franziska Lautenschläger
231 [GO] 2021―Jul―12 Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion Mohd Zulkifli Salleh, Jeremy P. Derrick, Zakuan Zainy Deris
232 [GO] 2021―Jul―05 Conventional and Unconventional Approaches for Innovative Drug Treatments in COVID-19: Looking Outside of Plato’s Cave George J. Kontoghiorghes, Annita Kolnagou, Stella Fetta, Christina N. Kontoghiorghe
233 [GO] 2021―Jul―01 Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4 Carmela Conte
234 [GO] 2021―Jul―01 Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies Christie Joshi, Viren Jadeja, Heping Zhou
235 [GO] 2021―Jul―01 Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation Giuliano Ramadori
236 [GO] 2021―Jun―30 Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19 Satyavani Kaliamurthi, Gur�an Selvaraj, Chandrabose Selvaraj, Sanjeev Kumar Singh, Dong-Qing Wei, Gilles H. Peslherbe
237 [GO] 2021―Jun―30 Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment Xiaoqiang Huang, Robin Pearce, Gilbert S. Omenn, Yang Zhang
238 [GO] 2021―Jun―30 Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury-The Current State of Knowledge and Future Perspectives Iwona Smarz-Widelska, Ewelina Grywalska, Izabela Morawska, Alicja Forma, Adam Michalski, Sebastian Mertowski, et al. (+5)
239 [GO] 2021―Jun―30 Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of Mpro and Its Antiviral Activity in Cells against SARS-CoV-2 Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, Luana Bagnoli, Ornelio Rosati, Francesca Marini, et al. (+16)
240 [GO] 2021―Jun―29 C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age Isabella Zanella, Eliana Zacchi, Simone Piva, Massimiliano Filosto, Giada Beligni, Diana Alaverdian, et al. (+8)
241 [GO] 2021―Jun―29 Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators Daniela Ricci, Marilena Paola Etna, Fabiana Rizzo, Silvia Sandini, Martina Severa, Eliana Marina Coccia
242 [GO] 2021―Jun―29 Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study Kirsten Cameron, Lina Rozano, Marco Falasca, Ricardo L. Mancera
243 [GO] 2021―Jun―28 COVID-19 Lockdowns May Reduce Resistance Genes Diversity in the Human Microbiome and the Need for Antibiotics João S. Rebelo, Célia P. F. Domingues, Francisco Dionisio, Manuel C. Gomes, Ana Botelho, Teresa Nogueira
244 [GO] 2021―Jun―28 De novo ssRNA Aptamers against the SARS-CoV-2 Main Protease: In Silico Design and Molecular Dynamics Simulation Francesco Morena, Chiara Argentati, Ilaria Tortorella, Carla Emiliani, Sabata Martino
245 [GO] 2021―Jun―28 Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles You-Zhe Lin, Yi-Chun Shen, Wan-Rong Wu, Wei-Jan Wang, Yuan-Liang Wang, Chen-Yuan Lin, et al. (+2)
246 [GO] 2021―Jun―28 Brain Mechanisms of COVID-19-Sleep Disorders Oxana Semyachkina-Glushkovskaya, Aysel Mamedova, Valeria Vinnik, Maria Klimova, Elena Saranceva, Vasily Ageev, et al. (+4)
247 [GO] 2021―Jun―23 Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms Huseyin C. Yalcin, Vijayakumar Sukumaran, Mahmoud Khatib A. A. Al-Ruweidi, Samar Shurbaji
248 [GO] 2021―Jun―23 Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels? Tomoshige Kino, Irina Burd, James H. Segars
249 [GO] 2021―Jun―23 Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems Nguyen Phan Khoi Le, Corinna Herz, João Victor Dutra Gomes, Nadja Förster, Kyriaki Antoniadou, Verena Karolin Mittermeier-Kleßinger, et al. (+4)
250 [GO] 2021―Jun―21 Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives Marios Sagris, Panagiotis Theofilis, Alexios S. Antonopoulos, Costas Tsioufis, Evangelos Oikonomou, Charalambos Antoniades, et al. (+3)
251 [GO] 2021―Jun―21 Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2 Valeria De Pasquale, Miriam Shasa Quiccione, Simona Tafuri, Luigi Avallone, Luigi Michele Pavone
252 [GO] 2021―Jun―18 SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of “the New Normal with COVID-19 Kenichi Imai, Hajime Tanaka
253 [GO] 2021―Jun―18 Studying SARS-CoV-2 with Fluorescence Microscopy Lidia V. Putlyaeva, Konstantin A. Lukyanov
254 [GO] 2021―Jun―18 Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences Nikita Abramenko, Fréderic Vellieux, Petra Tesařová, Zdeněk Kejík, Robert Kaplánek, Lukáš Lacina, et al. (+6)
255 [GO] 2021―Jun―17 The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA Olga A. Postnikova, Sheetal Uppal, Weiliang Huang, Maureen A. Kane, Rafael Villasmil, Igor B. Rogozin, et al. (+2)
256 [GO] 2021―Jun―17 Antiviral Activity of Two Marine Carotenoids against SARS-CoV-2 Virus Entry In Silico and In Vitro Sung-Kun Yim, Inhee Kim, Boyd Warren, Jungwon Kim, Kyoojin Jung, Bosung Ku
257 [GO] 2021―Jun―17 More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells Sonia Di Gaetano, Domenica Capasso, Pietro Delre, Luciano Pirone, Michele Saviano, Emilia Pedone, Giuseppe Felice Mangiatordi
258 [GO] 2021―Jun―07 Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors Alessia Mongelli, Veronica Barbi, Michela Gottardi Zamperla, Sandra Atlante, Luana Forleo, Marialisa Nesta, et al. (+11)
259 [GO] 2021―Jun―07 In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3′-UTR María Asunción Barreda-Manso, Manuel Nieto-Díaz, Altea Soto, Teresa Muñoz-Galdeano, David Reigada, Rodrigo M. Maza
260 [GO] 2021―Jun―07 Nucleic Acid Testing of SARS-CoV-2 Hee Min Yoo, Il-Hwan Kim, Seil Kim
261 [GO] 2021―Jun―01 Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis Adriana Georgescu, Maya Simionescu
262 [GO] 2021―Jun―01 Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications Alessandra Stasi, Rossana Franzin, Marco Fiorentino, Enrico Squiccimarro, Giuseppe Castellano, Loreto Gesualdo
263 [GO] 2021―Jun―01 A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against Mycobacterium abscessus Taeho Kim, Bui-Thi-Bich Hanh, Boeun Heo, Nguyenthanh Quang, Yujin Park, Jihyeon Shin, et al. (+4)
264 [GO] 2021―Jun―01 Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses Morvarid Siri, Sanaz Dastghaib, Mozhdeh Zamani, Nasim Rahmani-Kukia, Kiarash Roustai Geraylow, Shima Fakher, et al. (+6)
265 [GO] 2021―May―31 The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis-A Literature Review Joanna Kulikowska, Agnieszka Kulczyńska-Przybik, Barbara Mroczko, Alina Kułakowska
266 [GO] 2021―May―28 The Immunological Role of the Placenta in SARS-CoV-2 Infection-Viral Transmission, Immune Regulation, and Lactoferrin Activity Iwona Bukowska-Ośko, Marta Popiel, Paweł Kowalczyk
267 [GO] 2021―May―28 Detection of SARS-CoV-2 RNA by a Multiplex Reverse-Transcription Loop-Mediated Isothermal Amplification Coupled with Melting Curves Analysis Igor P. Oscorbin, Georgiy Yu. Shevelev, Ksenia A. Pronyaeva, Andrey A. Stepanov, Darya V. Shamovskaya, Olga V. Mishukova, et al. (+2)
268 [GO] 2021―May―26 Induction of the Proinflammatory Chemokine Interleukin-8 Is Regulated by Integrated Stress Response and AP-1 Family Proteins Activated during Coronavirus Infection Qing Chun Zhu, Shumin Li, Li Xia Yuan, Rui Ai Chen, Ding Xiang Liu, To Sing Fung
269 [GO] 2021―May―26 Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? Changbo Qu, Gwenny M. Fuhler, Yihang Pan
270 [GO] 2021―May―24 Possible Beneficial Actions of Caffeine in SARS-CoV-2 Bianca S. Romero-Martínez, Luis M. Montaño, Héctor Solís-Chagoyán, Bettina Sommer, Gemma Lizbeth Ramírez-Salinas, Gloria E. Pérez-Figueroa, Edgar Flores-Soto
271 [GO] 2021―May―21 Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices? Jung-Hyun Won, Howard Lee
272 [GO] 2021―May―21 The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy Shirin Kouhpayeh, Laleh Shariati, Maryam Boshtam, Ilnaz Rahimmanesh, Mina Mirian, Yasaman Esmaeili, et al. (+7)
273 [GO] 2021―May―21 Existing Drugs Considered as Promising in COVID-19 Therapy Edyta Janik, Marcin Niemcewicz, Marcin Podogrocki, Joanna Saluk-Bijak, Michal Bijak
274 [GO] 2021―May―20 The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19 Valeria Iliadi, Ina Konstantinidou, Konstantina Aftzoglou, Sergios Iliadis, Theocharis G. Konstantinidis, Christina Tsigalou
275 [GO] 2021―May―20 Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19 Sueva Cantalupo, Vito Alessandro Lasorsa, Roberta Russo, Immacolata Andolfo, Giuseppe D’Alterio, Barbara Eleni Rosato, et al. (+15)
276 [GO] 2021―May―19 Contribution of Syndecans to the Cellular Entry of SARS-CoV-2 Anett Hudák, Annamária Letoha, László Szilák, Tamás Letoha
277 [GO] 2021―May―17 Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D Ming-Yieh Peng, Wen-Chih Liu, Jing-Quan Zheng, Chien-Lin Lu, Yi-Chou Hou, Cai-Mei Zheng, et al. (+3)
278 [GO] 2021―May―13 Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19 Tatsuya Maruhashi, Yukihito Higashi
279 [GO] 2021―May―10 Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West? Naoki Yamamoto, Rain Yamamoto, Yasuo Ariumi, Masashi Mizokami, Kunitada Shimotohno, Hiroshi Yoshikura
280 [GO] 2021―May―07 High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia Gaowa Bai, Daisuke Furushima, Toshiro Niki, Takashi Matsuba, Yosuke Maeda, Atsushi Takahashi, et al. (+2)
281 [GO] 2021―May―07 IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein Zorana Lopandić, Isidora Protić-Rosić, Aleksandra Todorović, Sofija Glamočlija, Marija Gnjatović, Danica Ćujic, Marija Gavrović-Jankulović
282 [GO] 2021―May―02 The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer Oana-Stefana Purcaru, Stefan-Alexandru Artene, Edmond Barcan, Cristian Adrian Silosi, Ilona Stanciu, Suzana Danoiu, et al. (+3)
283 [GO] 2021―Apr―30 Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients Judith Marín-Corral, Jose Rodríguez-Morató, Alex Gomez-Gomez, Sergi Pascual-Guardia, Rosana Muñoz-Bermúdez, Anna Salazar-Degracia, et al. (+6)
284 [GO] 2021―Apr―29 ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis Anastasia V. Poznyak, Evgeny E. Bezsonov, Ali H. Eid, Tatyana V. Popkova, Ludmila V. Nedosugova, Antonina V. Starodubova, Alexander N. Orekhov
285 [GO] 2021―Apr―27 Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review Aneta Aleksova, Giulia Gagno, Gianfranco Sinagra, Antonio Paolo Beltrami, Milijana Janjusevic, Giuseppe Ippolito, et al. (+3)
286 [GO] 2021―Apr―27 Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences Agnieszka Dettlaff-Pokora, Julian Swierczynski
287 [GO] 2021―Apr―27 PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-“Rheumatic Fever” of the 21st Century? Violetta Opoka-Winiarska, Ewelina Grywalska, Jacek Roliński
288 [GO] 2021―Apr―26 SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19 Alexandra M. Huffman, Samar Rezq, Jelina Basnet, Licy L. Yanes Cardozo, Damian G. Romero
289 [GO] 2021―Apr―19 COVID-19: Direct and Indirect Mechanisms of Statins Agnieszka Pawlos, Mateusz Niedzielski, Paulina Gorzelak-Pabiś, Marlena Broncel, Ewelina Woźniak
290 [GO] 2021―Apr―15 Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19 Gustavo José da Silva Pereira, Anderson Henrique França Figueredo Leão, Adolfo Garcia Erustes, Ingrid Beatriz de Melo Morais, Talita Aparecida de Moraes Vrechi, Lucas dos Santos Zamarioli, et al. (+9)
291 [GO] 2021―Apr―15 Cardiovascular Outcomes in the Acute Phase of COVID-19 Hiroki Nakano, Kazuki Shiina, Hirofumi Tomiyama
292 [GO] 2021―Apr―15 Neurological Complications of COVID-19: Underlying Mechanisms and Management Ghaydaa A. Shehata, Kevin C. Lord, Michaela C. Grudzinski, Mohamed Elsayed, Ramy Abdelnaby, Hatem A. Elshabrawy
293 [GO] 2021―Apr―12 SARS-CoV-2 Papain-Like Protease Potential Inhibitors-In Silico Quantitative Assessment Adam Stasiulewicz, Alicja W. Maksymiuk, Mai Lan Nguyen, Barbara Bełza, Joanna I. Sulkowska
294 [GO] 2021―Apr―08 Influence of Previous COVID-19 and Mastitis Infections on the Secretion of Brain-Derived Neurotrophic Factor and Nerve Growth Factor in Human Milk Veronique Demers-Mathieu, Dustin J. Hines, Rochelle M. Hines, Sirima Lavangnananda, Shawn Fels, Elena Medo
295 [GO] 2021―Apr―06 Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis Radha Gopalaswamy, Selvakumar Subbian
296 [GO] 2021―Mar―26 Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection Marina R. Alexander, Aaron M. Brice, Petrus Jansen van Vuren, Christina L. Rootes, Leon Tribolet, Christopher Cowled, et al. (+2)
297 [GO] 2021―Mar―22 Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role? Valeria Guglielmi, Luca Colangeli, Monica D’Adamo, Paolo Sbraccia
298 [GO] 2021―Mar―22 Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-β in Triggering Inflammatory Signals in Cells of Distant Organ Subhayan Sur, Mousumi Khatun, Robert Steele, T. Scott Isbell, Ranjit Ray, Ratna B. Ray
299 [GO] 2021―Mar―22 Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro Hirofumi Ohashi, Feng Wang, Frank Stappenbeck, Kana Tsuchimoto, Chisa Kobayashi, Wakana Saso, et al. (+10)
300 [GO] 2021―Mar―22 Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions Fedor Simko, Jaroslav Hrenak, Michaela Adamcova, Ludovit Paulis
301 [GO] 2021―Mar―19 Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases Camillo Ricordi, Francesca Pacifici, Giacomo Lanzoni, Anna Teresa Palamara, Enrico Garaci, David Della-Morte
302 [GO] 2021―Mar―17 Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence Corrado Pelaia, Cecilia Calabrese, Eugenio Garofalo, Andrea Bruni, Alessandro Vatrella, Girolamo Pelaia
303 [GO] 2021―Mar―17 SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity Szu-Wei Huang, Sheng-Fan Wang
304 [GO] 2021―Mar―16 Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic Negin Kazemian, Dina Kao, Sepideh Pakpour
305 [GO] 2021―Mar―15 Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis Raymond Chu, Charmaine van Eeden, Sneha Suresh, Wendy I. Sligl, Mohammed Osman, Jan Willem Cohen Tervaert
306 [GO] 2021―Mar―15 Metal-Bound Methisazone; Novel Drugs Targeting Prophylaxis and Treatment of SARS-CoV-2, a Molecular Docking Study Ahmed Abdelaal Ahmed Mahmoud M. Alkhatip, Michail Georgakis, Lucio R. Montero Valenzuela, Mohamed Hamza, Ehab Farag, Jaqui Hodgkinson, et al. (+12)
307 [GO] 2021―Mar―10 A Novel Computational Approach for the Discovery of Drug Delivery System Candidates for COVID-19 Taeheum Cho, Hyo-Sang Han, Junhyuk Jeong, Eun-Mi Park, Kyu-Sik Shim
308 [GO] 2021―Mar―08 Interactions of SARS-CoV-2 with the Blood-Brain Barrier Michelle A. Erickson, Elizabeth M. Rhea, Rachel C. Knopp, William A. Banks
309 [GO] 2021―Mar―08 Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19 Linhua Tian, Elzafir B. Elsheikh, Paul N. Patrone, Anthony J. Kearsley, Adolfas K. Gaigalas, Sarah Inwood, et al. (+3)
310 [GO] 2021―Mar―05 The Role of Immunogenetics in COVID-19 Fanny Pojero, Giuseppina Candore, Calogero Caruso, Danilo Di Bona, David A. Groneberg, Mattia E. Ligotti, et al. (+2)
311 [GO] 2021―Mar―05 Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries Chunguang Liang, Elena Bencurova, Eric Psota, Priya Neurgaonkar, Martina Prelog, Carsten Scheller, Thomas Dandekar
312 [GO] 2021―Mar―05 CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands Georgina Bezzi, Ernesto J. Piga, Andrés Binolfi, Pablo Armas
313 [GO] 2021―Mar―01 Nutraceuticals in the Prevention of Viral Infections, Including COVID-19, among the Pediatric Population: A Review of the Literature Giuseppe Fabio Parisi, Giuseppe Carota, Carlo Castruccio Castracani, Mariarita Spampinato, Sara Manti, Maria Papale, et al. (+3)
314 [GO] 2021―Mar―01 COVID-19 and Diagnostic Testing for SARS-CoV-2 by RT-qPCR-Facts and Fallacies Stephen Bustin, Reinhold Mueller, Gregory Shipley, Tania Nolan
315 [GO] 2021―Feb―27 SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids Marta Trevisan, Silvia Riccetti, Alessandro Sinigaglia, Luisa Barzon
316 [GO] 2021―Feb―22 Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions Robert Root-Bernstein
317 [GO] 2021―Feb―20 Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2 André Fischer, Manuel Sellner, Karolina Mitusińska, Maria Bzówka, Markus A. Lill, Artur Góra, Martin Smieško
318 [GO] 2021―Feb―18 Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 Barbara Malinowska, Marta Baranowska-Kuczko, Aleksandra Kicman, Eberhard Schlicker
319 [GO] 2021―Feb―17 Adjunctive Nutraceutical Therapies for COVID-19 Lalita Subedi, Stephanie Tchen, Bhakta Prasad Gaire, Bingren Hu, Kurt Hu
320 [GO] 2021―Feb―15 Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library Yu Jung Kim, Min Ho Lee, Se-Ra Lee, Hyo-Young Chung, Kwangmin Kim, Tae Gyu Lee, Dae Young Kim
321 [GO] 2021―Feb―14 Bioactive Alkaloids from Genus Aspergillus: Mechanistic Interpretation of Their Antimicrobial and Potential SARS-CoV-2 Inhibitory Activity Using Molecular Modelling Fadia S. Youssef, Elham Alshammari, Mohamed L. Ashour
322 [GO] 2021―Feb―13 Platelet Lysate Nebulization Protocol for the Treatment of COVID-19 and Its Sequels: Proof of Concept and Scientific Rationale Maider Beitia, Diego Delgado, Pello Sánchez, Ana Vallejo de la Cueva, José Ramón Cugat, Mikel Sánchez
323 [GO] 2021―Feb―12 Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers Veronique Demers-Mathieu, Ciera DaPra, Gabrielle Mathijssen, David A. A. Sela, Kirsi M. M. Jarvinen, Antti Seppo, et al. (+2)
324 [GO] 2021―Feb―12 Detection of Coronaviruses Using RNA Toehold Switch Sensors Soan Park, Jeong Wook Lee
325 [GO] 2021―Feb―12 Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19 Markus Blaess, Lars Kaiser, Oliver Sommerfeld, René Csuk, Hans-Peter Deigner
326 [GO] 2021―Feb―12 The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis Angela Dziedzic, Joanna Saluk-Bijak, Elzbieta Miller, Marcin Niemcewicz, Michal Bijak
327 [GO] 2021―Feb―10 Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics Hyung Muk Choi, Soo Youn Moon, Hyung In Yang, Kyoung Soo Kim
328 [GO] 2021―Feb―10 ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19? Silvia D’Amico, Patrizia Tempora, Valeria Lucarini, Ombretta Melaiu, Stefania Gaspari, Mattia Algeri, Doriana Fruci
329 [GO] 2021―Feb―10 In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface Bruno O. Villoutreix, Vincent Calvez, Anne-Geneviève Marcelin, Abdel-Majid Khatib
330 [GO] 2021―Feb―09 Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis Sarah Seeherman, Yuichiro J. Suzuki
331 [GO] 2021―Feb―05 Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology George Anderson, Annalucia Carbone, Gianluigi Mazzoccoli
332 [GO] 2021―Feb―04 Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2 Yejin Jang, Jin Soo Shin, Myoung Kyu Lee, Eunhye Jung, Timothy An, Uk-Il Kim, et al. (+2)
333 [GO] 2021―Feb―04 Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking Nischal Karki, Niraj Verma, Francesco Trozzi, Peng Tao, Elfi Kraka, Brian Zoltowski
334 [GO] 2021―Jan―30 Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses Andrea Citarella, Davide Gentile, Antonio Rescifina, Anna Piperno, Barbara Mognetti, Giorgio Gribaudo, et al. (+4)
335 [GO] 2021―Jan―30 Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking Nischal Karki, Niraj Verma, Francesco Trozzi, Peng Tao, Elfi Kraka, Brian Zoltowski
336 [GO] 2021―Jan―29 Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium Fusobacterium nucleatum in Human Respiratory Epithelial Cells Yuwa Takahashi, Norihisa Watanabe, Noriaki Kamio, Sho Yokoe, Ryuta Suzuki, Shuichi Sato, et al. (+2)
337 [GO] 2021―Jan―28 Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic Fabio Arena, Simona Pollini, Gian Maria Rossolini, Maurizio Margaglione
338 [GO] 2021―Jan―28 The Central Role of Fibrinolytic Response in COVID-19-A Hematologist’s Perspective Hau C. Kwaan, Paul F. Lindholm
339 [GO] 2021―Jan―26 Mediterranean Diet for the Prevention of Gestational Diabetes in the Covid-19 Era: Implications of Il-6 In Diabesity Anna Lucia Fedullo, Antonio Schiattarella, Maddalena Morlando, Anna Raguzzini, Elisabetta Toti, Pasquale De Franciscis, Ilaria Peluso
340 [GO] 2021―Jan―25 A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections Abdulaziz Alamri, Derek Fisk, Deepak Upreti, Sam K. P. Kung
341 [GO] 2021―Jan―20 Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells? Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos
342 [GO] 2021―Jan―20 A Novel Approach to the Bioluminescent Detection of the SARS-CoV-2 ORF1ab Gene by Coupling Isothermal RNA Reverse Transcription Amplification with a Digital PCR Approach Zhongjie Fei, Rongbin Wei, Chu Cheng, Pengfeng Xiao
343 [GO] 2021―Jan―19 The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury Giovanni Zarrilli, Valentina Angerilli, Gianluca Businello, Marta Sbaraglia, Giulia Traverso, Francesco Fortarezza, et al. (+6)
344 [GO] 2021―Jan―08 Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics Rosa Terracciano, Mariaimmacolata Preianò, Annalisa Fregola, Corrado Pelaia, Tiziana Montalcini, Rocco Savino
345 [GO] 2021―Jan―01 Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus Valerie Bríd O’Leary, Oliver James Dolly, Cyril Höschl, Marie Černa, Saak Victor Ovsepian
346 [GO] 2020―Dec―23 Multiple Recombination Events and Strong Purifying Selection at the Origin of SARS-CoV-2 Spike Glycoprotein Increased Correlated Dynamic Movements Massimiliano S. Tagliamonte, Nabil Abid, Stefano Borocci, Elisa Sangiovanni, David A. Ostrov, Sergei L. Kosakovsky Pond, et al. (+3)
347 [GO] 2020―Dec―22 The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic Jung-Hyun Won, Howard Lee
348 [GO] 2020―Dec―21 Vascular Endothelial Glycocalyx Damage in COVID-19 Minako Yamaoka-Tojo
349 [GO] 2020―Dec―16 Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2? Stanislav R. Kurpe, Sergei Yu. Grishin, Alexey K. Surin, Alexander V. Panfilov, Mikhail V. Slizen, Saikat D. Chowdhury, Oxana V. Galzitskaya
350 [GO] 2020―Dec―15 Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease Márió Miczi, Mária Golda, Balázs Kunkli, Tibor Nagy, József Tőzsér, János András Mótyán
351 [GO] 2020―Dec―07 The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection Jessica Maiuolo, Rocco Mollace, Micaela Gliozzi, Vincenzo Musolino, Cristina Carresi, Sara Paone, et al. (+9)
352 [GO] 2020―Dec―04 Interrelated Mechanism by Which the Methide Quinone Celastrol, Obtained from the Roots of Tripterygium wilfordii, Inhibits Main Protease 3CLpro of COVID-19 and Acts as Superoxide Radical Scavenger Francesco Caruso, Manrose Singh, Stuart Belli, Molly Berinato, Miriam Rossi
353 [GO] 2020―Dec―02 Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2 Nadezhda V. Antipova, Tatyana D. Larionova, Andrei E. Siniavin, Maria A. Nikiforova, Vladimir A. Gushchin, Igor I. Babichenko, et al. (+3)
354 [GO] 2020―Nov―23 Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19 Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, Katia Mangano, Paolo Fagone, Eduard van Wijk, et al. (+9)
355 [GO] 2020―Nov―17 The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19 Alessandro Bellis, Ciro Mauro, Emanuele Barbato, Bruno Trimarco, Carmine Morisco
356 [GO] 2020―Nov―17 Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2 Elettra Barberis, Sara Timo, Elia Amede, Virginia V. Vanella, Chiara Puricelli, Giuseppe Cappellano, et al. (+19)
357 [GO] 2020―Nov―09 Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection Marco Festa, Clementina Sansone, Christophe Brunet, Fabio Crocetta, Luisa Di Paola, Michele Lombardo, et al. (+3)
358 [GO] 2020―Nov―05 Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2 Gennady Verkhivker
359 [GO] 2020―Nov―03 Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19 Chantelle Venter, Johannes Andries Bezuidenhout, Gert Jacobus Laubscher, Petrus Johannes Lourens, Janami Steenkamp, Douglas B. Kell, Etheresia Pretorius
360 [GO] 2020―Oct―31 Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury Federico Biscetti, Maria Margherita Rando, Elisabetta Nardella, Andrea Leonardo Cecchini, Piergiorgio Bruno, Raffaele Landolfi, Andrea Flex
361 [GO] 2020―Oct―29 Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets Harry Karmouty-Quintana, Rajarajan A. Thandavarayan, Steven P. Keller, Sandeep Sahay, Lavannya M. Pandit, Bindu Akkanti
362 [GO] 2020―Oct―26 Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19 Jan Brábek, Milan Jakubek, Fréderic Vellieux, Jiří Novotný, Michal Kolář, Lukáš Lacina, et al. (+5)
363 [GO] 2020―Oct―26 SARS-CoV-2/Renin-Angiotensin System: Deciphering the Clues for a Couple with Potentially Harmful Effects on Skeletal Muscle Andrea Gonzalez, Josué Orozco-Aguilar, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio
364 [GO] 2020―Oct―06 Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2 Annika Rogstam, Maria Nyblom, Signe Christensen, Celeste Sele, Vladimir O. Talibov, Therese Lindvall, et al. (+5)
365 [GO] 2020―Sep―29 Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19 Eileen M McGowan, Nahal Haddadi, Najah T. Nassif, Yiguang Lin
366 [GO] 2020―Sep―28 Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans Rajneesh Srivastava, Swapna Vidhur Daulatabad, Mansi Srivastava, Sarath Chandra Janga
367 [GO] 2020―Sep―22 Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases Manuel Scimeca, Nicoletta Urbano, Rita Bonfiglio, Manuela Montanaro, Elena Bonanno, Orazio Schillaci, Alessandro Mauriello
368 [GO] 2020―Sep―18 Stem Cells Secretome from Oral Tissue Could Represent a Promising Therapeutic Approach in COVID-19-Disease? Francesca Diomede, Guya D. Marconi, Luigia Fonticoli, Jacopo Pizzicannella, Oriana Trubiani
369 [GO] 2020―Sep―16 Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic Strategies Arun Samidurai, Anindita Das
370 [GO] 2020―Sep―15 SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? Elisabetta Meacci, Mercedes Garcia-Gil, Federica Pierucci
371 [GO] 2020―Sep―09 Smoking and COVID-19: Adding Fuel to the Flame Vivek K. Kashyap, Anupam Dhasmana, Andrew Massey, Sudhir Kotnala, Nadeem Zafar, Meena Jaggi, et al. (+2)
372 [GO] 2020―Sep―09 Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody Assay Carol Ho-Yan Fong, Jian-Piao Cai, Thrimendra Kaushika Dissanayake, Lin-Lei Chen, Charlotte Yee-Ki Choi, Lok-Hin Wong, et al. (+11)
373 [GO] 2020―Sep―04 Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System Jairo Lumpuy-Castillo, Ana Lorenzo-Almorós, Ana María Pello-Lázaro, Carlos Sánchez-Ferrer, Jesús Egido, José Tuñón, et al. (+2)
374 [GO] 2020―Sep―03 The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19) Neelu Batra, Cristabelle De Souza, Jyoti Batra, Alan G. Raetz, Ai-Ming Yu
375 [GO] 2020―Sep―01 Natural Killer Cell Dysfunction and Its Role in COVID-19 Charmaine van Eeden, Lamia Khan, Mohammed S. Osman, Jan Willem Cohen Tervaert
376 [GO] 2020―Aug―27 Using All-Atom Potentials to Refine RNA Structure Predictions of SARS-CoV-2 Stem Loops Christina Bergonzo, Andrea L. Szakal
377 [GO] 2020―Aug―20 Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity Wakako Sakaguchi, Nobuhisa Kubota, Tomoko Shimizu, Juri Saruta, Shinya Fuchida, Akira Kawata, et al. (+4)
378 [GO] 2020―Aug―18 Deciphering SARS-CoV-2 Virologic and Immunologic Features Grégorie Lebeau, Damien Vagner, Étienne Frumence, Franck Ah-Pine, Xavier Guillot, Estelle Nobécourt, et al. (+2)
379 [GO] 2020―Aug―14 New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine Davide Gentile, Virginia Fuochi, Antonio Rescifina, Pio Maria Furneri
380 [GO] 2020―Aug―13 Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications Konstantinos Farsalinos, Elias Eliopoulos, Demetres D. Leonidas, Georgios E. Papadopoulos, Socrates Tzartos, Konstantinos Poulas
381 [GO] 2020―Aug―12 Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics Andreas Ritter, Nina-Naomi Kreis, Frank Louwen, Juping Yuan
382 [GO] 2020―Aug―10 SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells Rolando Cannalire, Irina Stefanelli, Carmen Cerchia, Andrea R. Beccari, Sveva Pelliccia, Vincenzo Summa
383 [GO] 2020―Aug―07 Development and Evaluation of Novel and Highly Sensitive Single-Tube Nested Real-Time RT-PCR Assays for SARS-CoV-2 Detection Cyril Chik-Yan Yip, Siddharth Sridhar, Kit-Hang Leung, Anthony Chin-Ki Ng, Kwok-Hung Chan, Jasper Fuk-Woo Chan, et al. (+5)
384 [GO] 2020―Aug―04 COVID-19: The Immune Responses and Clinical Therapy Candidates Sareh Zhand, Marie Saghaeian Jazi, Saeed Mohammadi, Roozbeh Tarighati Rasekhi, Ghassem Rostamian, Mohammad Reza Kalani, et al. (+3)
385 [GO] 2020―Aug―04 Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection Mathieu Gand, Kevin Vanneste, Isabelle Thomas, Steven Van Gucht, Arnaud Capron, Philippe Herman, et al. (+2)
386 [GO] 2020―Aug―03 SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms Manuela Pennisi, Giuseppe Lanza, Luca Falzone, Francesco Fisicaro, Raffaele Ferri, Rita Bella
387 [GO] 2020―Jul―29 A Rapid, Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19 Franklin Wang-Ngai Chow, Tony Tat-Yin Chan, Anthony Raymond Tam, Suhui Zhao, Weiming Yao, Joshua Fung, et al. (+21)
388 [GO] 2020―Jul―28 Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? Mauro Giorgi, Silvia Cardarelli, Federica Ragusa, Michele Saliola, Stefano Biagioni, Giancarlo Poiana, et al. (+2)
389 [GO] 2020―Jul―28 Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations Alessandro Grottesi, Neva Bešker, Andrew Emerson, Candida Manelfi, Andrea R. Beccari, Francesco Frigerio, et al. (+3)
390 [GO] 2020―Jul―22 Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes Corlia Grobler, Siphosethu C. Maphumulo, L. Mireille Grobbelaar, Jhade C. Bredenkamp, Gert J. Laubscher, Petrus J. Lourens, et al. (+3)
391 [GO] 2020―Jul―22 Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19? Marta Menegazzi, Rachele Campagnari, Mariarita Bertoldi, Rosalia Crupi, Rosanna Di Paola, Salvatore Cuzzocrea
392 [GO] 2020―Jul―22 A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0 Silvia Gervasoni, Giulio Vistoli, Carmine Talarico, Candida Manelfi, Andrea R. Beccari, Gabriel Studer, et al. (+4)
393 [GO] 2020―Jul―21 COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis Alessandra Fierabracci, Andrea Arena, Paolo Rossi
394 [GO] 2020―Jul―20 Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic Navid Rabiee, Mojtaba Bagherzadeh, Amir Ghasemi, Hossein Zare, Sepideh Ahmadi, Yousef Fatahi, et al. (+5)
395 [GO] 2020―Jul―20 The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity? Cyrielle Holuka, Myriam P. Merz, Sara B. Fernandes, Eleftheria G. Charalambous, Snehaa V. Seal, Nathalie Grova, Jonathan D. Turner
396 [GO] 2020―Jul―14 COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks Markus Blaess, Lars Kaiser, Martin Sauer, René Csuk, Hans-Peter Deigner
397 [GO] 2020―Jul―14 Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation Elena Campione, Terenzio Cosio, Luigi Rosa, Caterina Lanna, Stefano Di Girolamo, Roberta Gaziano, et al. (+2)
398 [GO] 2020―Jul―07 Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting Ali Hosseini Rad SM, Alexander D. McLellan
399 [GO] 2020―Jul―06 Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications Alessandro Allegra, Mario Di Gioacchino, Alessandro Tonacci, Caterina Musolino, Sebastiano Gangemi
400 [GO] 2020―Jun―30 Putative Roles for Peptidylarginine Deiminases in COVID-19 Elif Damla Arisan, Pinar Uysal-Onganer, Sigrun Lange
401 [GO] 2020―Jun―30 Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity Paola Gualtieri, Carmela Falcone, Lorenzo Romano, Sebastiano Macheda, Pierpaolo Correale, Pietro Arciello, et al. (+2)
402 [GO] 2020―Jun―30 Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review Marzena Wyganowska-Swiatkowska, Michal Nohawica, Katarzyna Grocholewicz, Gerard Nowak
403 [GO] 2020―Jun―26 Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic Alejandro Llanes, Carlos M. Restrepo, Zuleima Caballero, Sreekumari Rajeev, Melissa A. Kennedy, Ricardo Lleonart
404 [GO] 2020―Jun―26 SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction Cheorl-Ho Kim
405 [GO] 2020―Jun―23 Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs Tuna Toptan, Sebastian Hoehl, Sandra Westhaus, Denisa Bojkova, Annemarie Berger, Björn Rotter, et al. (+4)
406 [GO] 2020―Jun―23 The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors Antonio Vittorino Gaddi, Fabio Capello, Leonardo Aluigi, Pier Luigi Antignani, Annapaola Callegaro, Gavino Casu, et al. (+20)
407 [GO] 2020―Jun―02 Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? Sabrina Rahman Archie, Luca Cucullo
408 [GO] 2020―May―28 Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19 Isabella Orienti, Giovanna Angela Gentilomi, Giovanna Farruggia
409 [GO] 2020―May―28 Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases Xinling Wang, Shuai Xia, Qian Wang, Wei Xu, Weihua Li, Lu Lu, Shibo Jiang
410 [GO] 2020―May―28 Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? Francesca Rossi, Chiara Tortora, Maura Argenziano, Alessandra Di Paola, Francesca Punzo
411 [GO] 2020―May―28 Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition Aleix Gimeno, Júlia Mestres-Truyol, María José Ojeda-Montes, Guillem Macip, Bryan Saldivar-Espinoza, Adrià Cereto-Massagué, et al. (+2)
412 [GO] 2020―May―21 Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds André Fischer, Manuel Sellner, Santhosh Neranjan, Martin Smieško, Markus A. Lill
413 [GO] 2020―May―21 Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2 Lucia Longhitano, Daniele Tibullo, Cesarina Giallongo, Giacomo Lazzarino, Nicola Tartaglia, Sara Galimberti, et al. (+3)
414 [GO] 2020―May―21 Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility Jaideep Chakladar, Neil Shende, Wei Tse Li, Mahadevan Rajasekaran, Eric Y. Chang, Weg M. Ongkeko
415 [GO] 2020―May―18 The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target Mohamed Abu-Farha, Thangavel Alphonse Thanaraj, Mohammad G. Qaddoumi, Anwar Hashem, Jehad Abubaker, Fahd Al-Mulla
416 [GO] 2020―May―15 Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19 Valentino Clemente, Padraig D’Arcy, Martina Bazzaro
417 [GO] 2020―May―14 COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Donato Gemmati, Barbara Bramanti, Maria Luisa Serino, Paola Secchiero, Giorgio Zauli, Veronica Tisato
418 [GO] 2020―May―12 Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation Joyce Kelly R. da Silva, Pablo Luis Baia Figueiredo, Kendall G. Byler, William N. Setzer
419 [GO] 2020―May―11 SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment Marcella Prete, Elvira Favoino, Giacomo Catacchio, Vito Racanelli, Federico Perosa
420 [GO] 2020―May―08 Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity Andrea Picchianti Diamanti, Maria Manuela Rosado, Claudio Pioli, Giorgio Sesti, Bruno Laganà
421 [GO] 2020―May―07 Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells Manoocher Soleimani
422 [GO] 2020―May―04 Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Tzu-Heng Wu, Chia-Chen Chang, Ching-Hsu Yang, Wei-Yin Lin, Tan Joy Ee, Chii-Wann Lin
423 [GO] 2020―May―04 SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation Young-Sheng Chang, Bo-Han Ko, Jyh-Cherng Ju, Hsin-Hou Chang, Su-Hua Huang, Cheng-Wen Lin
424 [GO] 2020―Apr―28 Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work Giovanni Messina, Rita Polito, Vincenzo Monda, Luigi Cipolloni, Nunzio Di Nunno, Giulio Di Mizio, et al. (+9)
425 [GO] 2020―Apr―28 Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design Maria Bzówka, Karolina Mitusińska, Agata Raczyńska, Aleksandra Samol, Jack A. Tuszyński, Artur Góra
426 [GO] 2020―Apr―24 COVID-19 and RAS: Unravelling an Unclear Relationship Damiano D’Ardes, Andrea Boccatonda, Ilaria Rossi, Maria Teresa Guagnano, Francesca Santilli, Francesco Cipollone, Marco Bucci
427 [GO] 2020―Apr―24 RT-qPCR Testing of SARS-CoV-2: A Primer Stephen A. Bustin, Tania Nolan
428 [GO] 2020―Apr―23 Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D Sandro La Vignera, Rossella Cannarella, Rosita A. Condorelli, Francesco Torre, Antonio Aversa, Aldo E. Calogero
429 [GO] 2020―Apr―21 COVID-19 Drug Discovery Using Intensive Approaches Ayumu Asai, Masamitsu Konno, Miyuki Ozaki, Chihiro Otsuka, Andrea Vecchione, Takahiro Arai, et al. (+8)
430 [GO] 2020―Apr―21 A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 Renfei Lu, Xiuming Wu, Zhenzhou Wan, Yingxue Li, Xia Jin, Chiyu Zhang
431 [GO] 2020―Apr―13 A Review of SARS-CoV-2 and the Ongoing Clinical Trials Yung-Fang Tu, Chian-Shiu Chien, Aliaksandr A. Yarmishyn, Yi-Ying Lin, Yung-Hung Luo, Yi-Tsung Lin, et al. (+6)
432 [GO] 2020―Apr―09 Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens Cyril Chik-Yan Yip, Chi-Chun Ho, Jasper Fuk-Woo Chan, Kelvin Kai-Wang To, Helen Shuk-Ying Chan, Sally Cheuk-Ying Wong, et al. (+12)
433 [GO] 2020―Mar―25 Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? Samir Jawhara
 [1] 

433 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.158 sec